Range
- - -
Vol / Avg.
-/7.8M
Div / Yield
-
52 Wk
1 - 2.75
Mkt Cap
491.5M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.11
Shares
393.2M
Outstanding
393.2M
Total Float
366.9M
Benzinga - May 25, 2021, 6:50AM
Benzinga - May 6, 2021, 10:56AM
Benzinga - May 6, 2021, 7:23AM
Benzinga - Apr 9, 2021, 7:44AM
Benzinga - Apr 8, 2021, 4:25PM
Benzinga - Apr 8, 2021, 4:12PM
Benzinga - Mar 2, 2021, 7:26AM
Benzinga - Feb 11, 2021, 9:03AM
Benzinga - Feb 11, 2021, 9:03AM
Benzinga - Feb 10, 2021, 4:35PM
Benzinga - Feb 10, 2021, 4:05PM
load more
Sector: Health Care.Industry: Pharmaceuticals
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.120-0.110 0.0100
REV19.770M19.866M96.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TXMDTherapeuticsMD-0.8%491.5M

TherapeuticsMD Frequently Asked Questions

Q

How do I buy TherapeuticsMD (TXMD) stock?

A

You can purchase shares of TherapeuticsMD (: TXMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TherapeuticsMD's (TXMD) competitors?

A

Other companies in TherapeuticsMD’s space includes: Iterum Therapeutics (:ITRM), Aerie Pharmaceuticals (:AERI), Verona Pharma (:VRNA), Tarsus Pharmaceuticals (:TARS) and ANI Pharmaceuticals (:ANIP).

Q

What is the target price for TherapeuticsMD (TXMD) stock?

A

The latest price target for TherapeuticsMD (: TXMD) was reported by Jefferies on August 7, 2020. The analyst firm set a price target for 1.20 expecting TXMD to fall to within 12 months (a possible -4.00% downside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TherapeuticsMD (TXMD)?

A

The stock price for TherapeuticsMD (: TXMD) is $1.25 last updated Wed Jun 16 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does TherapeuticsMD (TXMD) pay a dividend?

A

There are no upcoming dividends for TherapeuticsMD.

Q

When is TherapeuticsMD (:TXMD) reporting earnings?

A
TherapeuticsMD’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is TherapeuticsMD (TXMD) going to split?

A

There is no upcoming split for TherapeuticsMD.

Q

What sector and industry does TherapeuticsMD (TXMD) operate in?

A

TherapeuticsMD is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the .